D
Repare Therapeutics Inc. RPTX
$2.13 -$0.01-0.24% NASDAQ
Recommendation
Prev Close
$2.13
Volume
1,417
Avg Vol (90D)
357,266
Market Cap
$91.34M
Dividend & Yield
--
52-Week Range
$0.89 - $4.07
P/E (TTM)
--
EPS (TTM)
-$1.70
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Halper Sadeh LLC Encourages RPTX, AXTA, BLFY, GDEN Shareholders to Contact the Firm to Discuss Their Rights
12/2/2025 - Globe Newswire
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights
11/28/2025 - PR Newswire
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR
11/28/2025 - PR Newswire
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights
11/27/2025 - Globe Newswire
HAPPY THANKSGIVING AND $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger RPTX, AXTA, WTG and SEMR
11/27/2025 - Globe Newswire
BIOTECHNOLOGY VALUE FUND L P Increases Stake in Repare Therapeutics Inc
11/25/2025 - GuruFocus
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Consensus Recommendation of "Hold" from Analysts
11/23/2025 - MarketBeat
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for ...
11/20/2025 - GuruFocus
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
11/20/2025 - Business Wire
Stock Traders Purchase High Volume of Call Options on Repare Therapeutics (NASDAQ:RPTX)
11/18/2025 - MarketBeat
Halper Sadeh LLC Encourages RPTX and SEE Shareholders to Contact the Firm to Discuss Their Rights
11/18/2025 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Repare Therapeutics Inc. (NASDAQ: RPTX)
11/17/2025 - Globe Newswire
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights
11/17/2025 - PR Newswire
Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open
11/17/2025 - Globe Newswire
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value
11/17/2025 - Benzinga
Repare Therapeutics just downgraded at TD Cowen, here's why
11/17/2025 - The Fly
repare finds fix biotech agrees xenotherapeutics buyout
11/17/2025 - FierceBiotech.com - Biotech
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. ...
11/15/2025 - GuruFocus
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders
11/15/2025 - Business Wire
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. ...
11/15/2025 - GuruFocus
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
11/15/2025 - PR Newswire
Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3
11/14/2025 - Zacks Investment Research
Repare Therapeutics (RPTX) to Be Acquired by XenoTherapeutics
11/14/2025 - GuruFocus
XenoTherapeutics to Acquire Repare Therapeutics (RPTX) in New Deal
11/14/2025 - GuruFocus
Repare Therapeutics trading resumes
11/14/2025 - The Fly
Income Statement
Total Revenue (TTM)
$11.87M
EBITDA (TTM)
-$76.46M
EBIT (TTM)
-$79.21M
Net Income (TTM)
-$72.20M
Balance Sheet
Total Assets (Q)
$126.75M
Total Debt (Q)
$342.00K
Total Liabilities (Q)
$11.62M
Book Value Per Share (Q)
$2.68
Cash Flow
Cash from Operations (TTM)
-$70.15M
Cash from Investing (TTM)
$62.33M
Cash from Financing (TTM)
$110.00K
Net Change in Cash (TTM)
-$7.72M
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Loading...
Beta
0.55
7-Day Total Return
0.71%
30-Day Total Return
13.03%
60-Day Total Return
22.83%
90-Day Total Return
34.49%
Year to Date Total Return
60.98%
1-Year Total Return
-33.80%
2-Year Total Return
-59.83%
3-Year Total Return
-87.11%
5-Year Total Return
-93.96%
52-week Low
Apr 10, 2025 - $0.89
52-week High
Dec 11, 2024 - $4.07
Valuation
Market Cap
$91.34M - Micro Cap
Enterprise Value
-$20.92M
Price/Sales (TTM)
7.71
Price/Book (Q)
0.79
Dividends and Shares
Shares Outstanding
43.05
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.reparerx.com
Phone Number
857 412 7018
Address
7171 Frederick-Banting, Building 2
Suite 270 - St-Laurent
Montreal, QC H4S 1Z9
Country
Canada
Year Founded
2016
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed